{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T02:10:50Z","timestamp":1778811050954,"version":"3.51.4"},"reference-count":10,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Grant-in-Aid for Scientific Research"},{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science, and Technology","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","brainanddevelopment.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brain and Development"],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.1016\/j.braindev.2017.01.010","type":"journal-article","created":{"date-parts":[[2017,2,24]],"date-time":"2017-02-24T11:16:35Z","timestamp":1487934995000},"page":"542-546","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Increased levels of anti-phosphatidylcholine and anti-phosphatidylethanolamine antibodies in pediatric patients with cerebral infarction"],"prefix":"10.1016","volume":"39","author":[{"given":"Seigo","family":"Korematsu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Yamada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroaki","family":"Miyahara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenji","family":"Ihara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.braindev.2017.01.010_b0005","first-page":"1301","article-title":"Antiphospholipid syndrome","author":"Erken","year":"2009"},{"key":"10.1016\/j.braindev.2017.01.010_b0010","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/S0022-2275(20)42840-8","article-title":"Phospholipid molecular species in human umbilical artery and vein endothelial cells","volume":"31","author":"Takamura","year":"1990","journal-title":"J Lipid Res"},{"key":"10.1016\/j.braindev.2017.01.010_b0015","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1055\/s-0037-1616089","article-title":"Anticardiolipin antibody assay: a methodological analysis for a better consensus in routine determinations. A cooperative project of the European Antiphospholipid Forum","volume":"86","author":"Tincani","year":"2001","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.braindev.2017.01.010_b0020","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1186\/1471-2431-14-116","article-title":"Central retinal vein occlusion in a pediatric patient with SLE and antiphospholipid antibodies without anti-cardiolipin or anti-\u03b22 glycoprotein I antibodies","volume":"14","author":"Korematsu","year":"2014","journal-title":"BMC Pediatr"},{"key":"10.1016\/j.braindev.2017.01.010_b0025","doi-asserted-by":"publisher","first-page":"6345","DOI":"10.1016\/j.vaccine.2014.09.053","article-title":"Elevated serum anti-phosphatidylcholine IgG antibodies in patients with influenza vaccination-associated optic neuritis","volume":"32","author":"Korematsu","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.braindev.2017.01.010_b0030","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1590\/S0004-282X2004000100007","article-title":"Cerebral infarct in children aged zero to fifteen years","volume":"62","author":"Noce","year":"2004","journal-title":"Arq Neurosiquiatr"},{"key":"10.1016\/j.braindev.2017.01.010_b0035","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1002\/art.10510","article-title":"Anti-\u03b22 glycoprotein I antibodies in pediatric systemic lupus erythematosus and antiphospholipid syndrome","volume":"47","author":"von Scheven","year":"2002","journal-title":"Arthiris Rheumatol"},{"key":"10.1016\/j.braindev.2017.01.010_b0040","first-page":"1369","article-title":"Antiphosphatidylethanolamine antibodies as the only antiphospholipid antibodies. I. Association with thrombosis and vascular cutaneous diseases","volume":"23","author":"Berard","year":"1996","journal-title":"J Rheumatol"},{"key":"10.1016\/j.braindev.2017.01.010_b0045","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1160\/TH12-07-0527","article-title":"Prevalence of antibodies to prothrombin in solid phase (aPT) and to phosphatidylserine-prothrombin complex (aPS\/PT) in patients with and without lupus anticoagulant","volume":"109","author":"Bertolaccini","year":"2013","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.braindev.2017.01.010_b0050","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1161\/01.ATV.3.4.389","article-title":"Plasma phosphatidylcholine\/free cholesterol ratio as an indicator for atherosclerosis","volume":"3","author":"Kuksis","year":"1983","journal-title":"Arteriosclerosis"}],"container-title":["Brain and Development"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0387760417300104?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0387760417300104?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,7,24]],"date-time":"2022-07-24T19:12:14Z","timestamp":1658689934000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0387760417300104"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6]]},"references-count":10,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2017,6]]}},"alternative-id":["S0387760417300104"],"URL":"https:\/\/doi.org\/10.1016\/j.braindev.2017.01.010","relation":{},"ISSN":["0387-7604"],"issn-type":[{"value":"0387-7604","type":"print"}],"subject":[],"published":{"date-parts":[[2017,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Increased levels of anti-phosphatidylcholine and anti-phosphatidylethanolamine antibodies in pediatric patients with cerebral infarction","name":"articletitle","label":"Article Title"},{"value":"Brain and Development","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.braindev.2017.01.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 The Japanese Society of Child Neurology. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}